dQ&A presented three research abstracts at the 85th Scientific Sessions of the American Diabetes Association (ADA), the world’s largest diabetes conference.
dQ&A is announcing upcoming data releases for our flagship products: Prescriber Perspectives (Europe) and Patient Voice (Europe).
Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.
